Suppr超能文献

[介入放射学在胰腺癌姑息治疗中的应用]

[Interventional radiology in the palliative treatment of pancreatic cancer].

作者信息

Mazza E, Carmignani L, Stecco A, Lucibello P

机构信息

Dipartimento di Fisiopatologia Clinica, Università di Firenze, Italia.

出版信息

Tumori. 1999 Jan-Feb;85(1 Suppl 1):S54-9.

Abstract

AIMS AND BACKGROUND

Pancreatic carcinoma often involves the head of the pancreas and obstructive jaundice is its earliest sign. It sometimes extends to celiac plexus and duodenum causing pain and bowel obstruction respectively. Only 20% of cases are totally resectable (stage I) at the time of diagnosis. Palliative treatment is the only available therapeutic option when the tumor extends surrounding organs or has given lymphatic metastases (stage II, III, IV). The aim of this study is to evaluate effectiveness of interventional radiology procedures on unresectable cancer palliative treatment.

METHODS

Between Jan 90 and Sep 98, 195 patients with unresectable pancreatic carcinoma received percutaneous treatments. They were 104 males and 91 females with mean age of 74 years (range, 48-95). One hundred eighty four patients underwent biliary drainage, six patients underwent celiac plexus block, two patients were treated by bowel stenting. Two patients received both biliary and bowel stents, one patient underwent biliary drainage and celiac plexus block.

RESULTS

Jaundice treatment was performed by placement of drainage catheters in 48 patients, polymeric endoprostheses in 58 and metallic stents in 77 (67 Wallstents). Biliary drainage was successful in all cases obtaining appreciable bilirubin serum levels reduction and jaundice regression in 175 patients (95%). In 44 patients Wallstents were placed during a single PTC session time ("one step" technique). In 21 cases (11%) peri-procedural complications occurred. Follow-up related to 85 patients shows survival rate covered between 30 and 570 days (mean, 142). Best survival values occurred in patients who underwent "one step" technique. Celiac plexus block was successful in 5/7 cases (71%) with no complications, total pain relief and withdrawal of pharmacological treatment. Bowel stenting achieved complete recanalization of intestinal loop in 2 cases but showed troubles related to management of these patients.

CONCLUSIONS

In patients with unresectable pancreatic carcinoma palliation is the only therapeutic option and has the purpose to achieve biliary tree decompression and eliminate jaundice associated symptoms, improving quality of life and reducing hospitalization. Jaundice relief is reachable by surgical, endoscopic or percutaneous approach. Surgical palliation is characterized by disadvantageous cost-effectiveness rate. Endoscopic and percutaneous palliations are alternative, although, in selected patients, percutaneous Wallstents placement by one step technique is perhaps the most successful procedure, showing high rate of technical outcome with low complications and short time spent in hospital. Celiac plexus block under CT guidance constitutes a reliable method for management of pain. At present bowel stricture treatment is surgical.

摘要

目的与背景

胰腺癌常累及胰头,梗阻性黄疸是其最早出现的症状。有时会蔓延至腹腔神经丛和十二指肠,分别导致疼痛和肠梗阻。诊断时仅有20%的病例可完全切除(I期)。当肿瘤侵犯周围器官或出现淋巴结转移(II期、III期、IV期)时,姑息治疗是唯一可行的治疗选择。本研究旨在评估介入放射学方法对不可切除胰腺癌姑息治疗的效果。

方法

1990年1月至1998年9月期间,195例不可切除胰腺癌患者接受了经皮治疗。其中男性104例,女性91例,平均年龄74岁(范围48 - 95岁)。184例患者接受了胆道引流,6例患者接受了腹腔神经丛阻滞,2例患者接受了肠道支架置入术。2例患者同时接受了胆道和肠道支架置入,1例患者接受了胆道引流和腹腔神经丛阻滞。

结果

48例患者通过放置引流导管进行黄疸治疗,58例患者使用聚合型内支架,77例患者使用金属支架(67枚Wallstent支架)。所有病例的胆道引流均成功,175例患者(95%)血清胆红素水平明显降低,黄疸消退。44例患者在单次经皮肝穿刺胆道造影(PTC)过程中放置了Wallstent支架(“一步法”技术)。21例患者(11%)发生了围手术期并发症。对85例患者的随访显示,生存率在30至570天之间(平均142天)。采用“一步法”技术的患者生存率最佳。腹腔神经丛阻滞在7例中有5例成功(71%),无并发症,疼痛完全缓解且停用了药物治疗。肠道支架置入术使2例患者的肠袢完全再通,但在这些患者的管理方面出现了问题。

结论

对于不可切除的胰腺癌患者,姑息治疗是唯一的治疗选择,目的是实现胆道减压,消除黄疸相关症状,提高生活质量并减少住院时间。黄疸缓解可通过手术、内镜或经皮途径实现。手术姑息治疗的成本效益比不佳。内镜和经皮姑息治疗是替代方法,不过,对于部分患者,经皮一步法放置Wallstent支架可能是最成功的方法,技术成功率高,并发症少,住院时间短。CT引导下的腹腔神经丛阻滞是管理疼痛的可靠方法。目前肠道狭窄的治疗是手术治疗。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验